Skip to main content

Senju Pharmaceutical Co.,Ltd.Senju Pharmaceutical Co.,Ltd.s

  • English
    日本語 English 中文
  • About Senju
  • Overseas Activities
  • Products
  • Research & Development
  • News
  • About Senju
    About Senju CEO Message Management Policy Company Profile Our Initiatives for Society/Environment Business Activities Research Laboratories Production
  • Overseas Activities
    Location Presence of Products
  • Products
    OTC Products, etc.
  • Research & Development
    Research & Development OTC Products, etc. Publications Meetings of the Minds
  • News
    News
  • JPCH
  • HOME
  • News

News

  • May 13, 2022 Announcement of Comprehensive Business Alliance(PDF)
  • April 13, 2022 Launch of Distribution of GAP and GAP-screener- the Gaze Analyzing Perimeters(PDF)
  • April 11, 2022 Launch of Distribution of the M22 IPL Model(PDF)
  • March 25, 2022 Launch of Distribution of Medical Devices(PDF)
  • December 9, 2021 Launch of a New Treatment for “Ranibizumab BS Intravitreal Injection Kit 10 mg/mL ‘Senju’”(PDF)
  • September 27, 2021 Ophthalmic VEGF Inhibitor Acquisition of Marketing Approval for “Ranibizumab BS Intravitreal Injection Kit 10 mg/mL ‘Senju’”(PDF)
  • December 9, 2019 Senju and Otsuka Launch a New Treatment for Glaucoma and Ocular Hypertension - AIBETA® Combination Ophthalmic Solution(PDF)
  • December 25, 2018 Launch of Neuroptika, Inc.(PDF)
  • September 14, 2016 Announcement of co-promotion of new glaucoma treatment(PDF)
  • June 11, 2014 License Agreement to Development and Commercialize Azithromycin Ophthalmic Solution Using DuraSite® in Japan
  • May 29, 2013 Collaboration License Agreement for the Development and Commercialization of Integrin Peptide Therapy
  • April 20, 2012 To be released on May 11, 2012: “AIPHAGAN® Ophthalmic Solution 0.1%”for the treatment of Glaucoma / Ocular Hypertension (PDF)
  • November 17, 2009 The approval of 『BRONUCK ®』 (bromfenac sodium hydrate ophthalmic solution)as an import drug in China(PDF)
More

You are leaving the Senju Pharmaceutical website

Thank you visiting Senju Pharmaceutical’s website.
You are now leaving our website through a link to an external website, which is not within our control.